Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes-Radioactive & Nonradioactive - Radiopharmacy & Clinical Production

In-house GMP manufacturing of [211At]PSMA-5 solution using an automated synthesizer for investigator-initiated clinical trials

Sadahiro Naka, Yoshifumi Shirakami, Naoya Jinno, Toshihiro Sakai, Kazuhiro Ooe, Kenta Kurimoto, Yukiyoshi Kon, Yin Xiaojie, Hiromitsu Haba, Atsushi Toyoshima and Tadashi Watabe
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242337;
Sadahiro Naka
1Osaka University Graduate School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshifumi Shirakami
2Osaka University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoya Jinno
2Osaka University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshihiro Sakai
3Hanwa Intelligent Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhiro Ooe
2Osaka University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenta Kurimoto
2Osaka University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukiyoshi Kon
2Osaka University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yin Xiaojie
4RIKEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiromitsu Haba
4RIKEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Toyoshima
2Osaka University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Watabe
1Osaka University Graduate School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 65 no. supplement 2 242337

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online June 9, 2024.

Copyright & Usage 
© 2024

Author Information

  1. Sadahiro Naka1,
  2. Yoshifumi Shirakami2,
  3. Naoya Jinno2,
  4. Toshihiro Sakai3,
  5. Kazuhiro Ooe2,
  6. Kenta Kurimoto2,
  7. Yukiyoshi Kon2,
  8. Yin Xiaojie4,
  9. Hiromitsu Haba4,
  10. Atsushi Toyoshima2 and
  11. Tadashi Watabe1
  1. 1Osaka University Graduate School of Medicine
  2. 2Osaka University
  3. 3Hanwa Intelligent Medical Center
  4. 4RIKEN

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: June 2024 to April 2025

AbstractFullPdf
Jun 20244700
Jul 202413800
Aug 202411000
Sep 20242800
Oct 20245200
Nov 20243900
Dec 20243300
Jan 20254000
Feb 20254000
Mar 20252000
Apr 20252500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In-house GMP manufacturing of [211At]PSMA-5 solution using an automated synthesizer for investigator-initiated clinical trials
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
In-house GMP manufacturing of [211At]PSMA-5 solution using an automated synthesizer for investigator-initiated clinical trials
Sadahiro Naka, Yoshifumi Shirakami, Naoya Jinno, Toshihiro Sakai, Kazuhiro Ooe, Kenta Kurimoto, Yukiyoshi Kon, Yin Xiaojie, Hiromitsu Haba, Atsushi Toyoshima, Tadashi Watabe
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242337;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In-house GMP manufacturing of [211At]PSMA-5 solution using an automated synthesizer for investigator-initiated clinical trials
Sadahiro Naka, Yoshifumi Shirakami, Naoya Jinno, Toshihiro Sakai, Kazuhiro Ooe, Kenta Kurimoto, Yukiyoshi Kon, Yin Xiaojie, Hiromitsu Haba, Atsushi Toyoshima, Tadashi Watabe
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242337;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Cu-Mediated 18F-Fluorination of Arylboronic Acids: Supressing Protodeboronation towards Advanced PET Imaging Agents
  • Assessment of the Radiochemical Purity and Chemical Identity of [225Ac]Ac-Labeled Radiotherapeutics by TLC and RP-HPLC
  • First in human study of 18F-FDOPA generated by photoredox radiofluorination
Show more Molecular Targeting Probes-Radioactive & Nonradioactive - Radiopharmacy & Clinical Production

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire